Vital Chemtech Ltd
Incorporated in 2014, Vital Chemtech Ltd manufactures and supplies phosphorous based chemicals[1]
- Market Cap ₹ 116 Cr.
- Current Price ₹ 48.4
- High / Low ₹ 69.4 / 35.4
- Stock P/E 13.0
- Book Value ₹ 47.0
- Dividend Yield 0.00 %
- ROCE 10.8 %
- ROE 8.67 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.03 times its book value
- Company's working capital requirements have reduced from 77.2 days to 46.4 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 6.04% over last 3 years.
- Earnings include an other income of Rs.8.56 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 5m | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 41 | 47 | 58 | 117 | 102 | 120 | 105 | |
| 37 | 41 | 46 | 102 | 97 | 113 | 100 | |
| Operating Profit | 4 | 6 | 12 | 15 | 5 | 8 | 6 |
| OPM % | 10% | 14% | 20% | 13% | 4.8% | 6% | 5% |
| 0 | 0 | 0 | 0 | 3 | 2 | 9 | |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 2 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 2 | 5 | 11 | 11 | 5 | 7 | 10 |
| Tax % | 55% | 38% | 26% | 30% | 18% | 31% | 14% |
| 1 | 3 | 8 | 8 | 4 | 5 | 9 | |
| EPS in Rs | 11.75 | 3.36 | 1.68 | 1.93 | 3.74 | ||
| Dividend Payout % | 0% | 0% | 0% | 15% | 30% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | -3% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 4% |
| TTM: | 93% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 24 | 24 | 24 | 24 | ||
| Reserves | 8 | 66 | 66 | 70 | 89 | ||
| 36 | 24 | 13 | 4 | 11 | |||
| 30 | 17 | 24 | 29 | 43 | |||
| Total Liabilities | 81 | 131 | 126 | 127 | 167 | ||
| 17 | 19 | 19 | 19 | 22 | |||
| CWIP | 0 | 0 | 0 | 2 | 0 | ||
| Investments | 3 | 15 | 34 | 22 | 24 | ||
| 61 | 96 | 73 | 84 | 121 | |||
| Total Assets | 81 | 131 | 126 | 127 | 167 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -13 | -10 | 15 | 9 | 7 | |||
| 1 | -20 | -28 | 1 | -21 | |||
| 18 | 53 | -16 | -10 | 15 | |||
| Net Cash Flow | 6 | 23 | -29 | 0 | -0 | ||
| Free Cash Flow | -22 | -14 | 13 | 5 | 4 | ||
| CFO/OP | -91% | -50% | 332% | 137% | 143% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 264 | 120 | 156 | 131 | 115 | ||
| Inventory Days | 87 | 57 | 59 | 38 | 100 | ||
| Days Payable | 265 | 57 | 106 | 96 | 171 | ||
| Cash Conversion Cycle | 87 | 120 | 109 | 73 | 44 | ||
| Working Capital Days | 59 | 128 | 98 | 87 | 46 | ||
| ROCE % | 15% | 5% | 8% | 11% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Cumulative Manufacturing Capacity MT |
|
||
| Number of Key Products Manufactured count |
|||
| Permanent Employees count |
|||
| CIF Value of Imports Rs. Lakhs |
|||
| FOB Value of Exports Rs. Lakhs |
|||
Extracted by Screener AI
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
4 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026.
-
Trading Window
27 June 2026 - Trading window closed from 1 July 2026 until 48 hours after Q1 FY26 results.
-
Updates
13 June 2026 - Vital Chemtech resubmitted FY26 audited results; appointed R J & Associates as cost auditor for FY27.
-
Press Release
11 June 2026 - Vital Synthesis received GPCB final consent order valid until March 26, 2031.
-
General Updates
11 June 2026 - Subsidiary Vital Synthesis received Gujarat PCB consent order valid until 26/03/2031.
Business Overview:[1][2]
VCL is a part of Vital Group which is a multi-product organization involved in Manufacturing, Contract Manufacturing and Exports of Chemicals. Company does manufacturing and supplying of Phosphorus Derivatives Products and Phosphorus base chemicals. It also does trading of its raw Material and is in the process of obtaining approval of Phosphorus Pentasulfide (P2S5)